{"id":"placebo-0-lotion","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a placebo formulation, this lotion lacks any active drug substance and relies on the patient's expectation and psychological response to treatment. The therapeutic benefit, if any, derives from placebo effect rather than pharmacological action. This formulation is typically used in clinical trials as a control comparator to assess the true efficacy of active treatments.","oneSentence":"Placebo 0% Lotion contains no active pharmaceutical ingredient and produces therapeutic effects solely through placebo response mechanisms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:25.363Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07404033","phase":"PHASE1","title":"ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"Sinomune Pharmaceutical Co., Ltd","startDate":"2026-02-27","conditions":"Seborrheic Dermatitis","enrollment":48},{"nctId":"NCT03292640","phase":"PHASE3","title":"A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2017-07-06","conditions":"Acne Vulgaris","enrollment":547},{"nctId":"NCT03290027","phase":"PHASE3","title":"A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2017-07-31","conditions":"Acne Vulgaris","enrollment":550},{"nctId":"NCT02624843","phase":"PHASE3","title":"Bioequivalence Study for Benzyl Alcohol Lotion 5%.","status":"COMPLETED","sponsor":"Akorn, Inc.","startDate":"2015-08","conditions":"Head Lice","enrollment":239},{"nctId":"NCT03337490","phase":"PHASE3","title":"A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice","status":"COMPLETED","sponsor":"Mayne Pharma International Pty Ltd","startDate":"2017-10-02","conditions":"Head Lice","enrollment":296}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo 0% Lotion","genericName":"Placebo 0% Lotion","companyName":"Mayne Pharma International Pty Ltd","companyId":"mayne-pharma-international-pty-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}